Cooper Companies (COO) Cash & Equivalents (2009 - 2026)
Cooper Companies' (COO) quarterly Cash & Equivalents came in at $138.8 million in Q2 2026, up 19.45% year-on-year from $116.2 million in Q2 2025, and up 11.13% quarter-over-quarter from $124.9 million in Q1 2026.
Cooper Companies (COO) Cash & Equivalents (2009 - 2026) Analysis & Trends
Cooper Companies' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $138.8 million for Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 19.45% year-over-year to $138.8 million in Q2 2026; TTM through Apr 2026 was $138.8 million, a 19.45% increase from a year earlier, with the FY2025 full-year figure at $110.6 million, up 2.79% from the prior year.
- Cash & Equivalents rose to $138.8 million in Q2 2026 per COO's latest filing, from $124.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $399.2 million in Q2 2022 and bottomed at $100.9 million in Q1 2025.
- The 5-year median for Cash & Equivalents is $119.5 million (2023), against an average of $150.8 million.
- Across the five-year window, Cash & Equivalents jumped 276.96% in 2022 and slumped 71.97% in 2023, its largest moves.
- Year by year, Cash & Equivalents stood at $138.2 million in 2022, then retreated by 12.59% to $120.8 million in 2023, then declined by 10.93% to $107.6 million in 2024, then advanced by 2.79% to $110.6 million in 2025, then gained by 25.5% to $138.8 million in 2026.
- Per Business Quant, the three latest COO Cash & Equivalents figures stand at $138.8 million (Q2 2026), $124.9 million (Q1 2026), and $110.6 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 2.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 138.80 Mn |
| Jan 31, 2026 | 124.90 Mn |
| Oct 31, 2025 | 110.60 Mn |
| Jul 31, 2025 | 124.90 Mn |
| Apr 30, 2025 | 116.20 Mn |
| Jan 31, 2025 | 100.90 Mn |
| Oct 31, 2024 | 107.60 Mn |
| Jul 31, 2024 | 109.70 Mn |
| Apr 30, 2024 | 112.40 Mn |
| Jan 31, 2024 | 135.20 Mn |
| Oct 31, 2023 | 120.80 Mn |
| Jul 31, 2023 | 117.30 Mn |
| Apr 30, 2023 | 111.90 Mn |
| Jan 31, 2023 | 118.20 Mn |
| Oct 31, 2022 | 138.20 Mn |
| Jul 31, 2022 | 246.30 Mn |
| Apr 30, 2022 | 399.20 Mn |
| Jan 31, 2022 | 280.70 Mn |
| Oct 31, 2021 | 95.90 Mn |
| Jul 31, 2021 | 112.20 Mn |